候选CSPG4突变与诱导多能干细胞建模揭示家族性精神分裂症少突胶质祖细胞功能障碍
该研究采用家系遗传发现与诱导多能干细胞(iPSC)功能分析,在家族性精神分裂症中观察到CSPG4两个罕见错义突变共分离。CSPG4A131T携带者来源的少突胶质祖细胞(OPC)表现翻译后加工、NG2亚细胞定位、细胞形态、活力及髓鞘化潜能异常,且携带者脑白质完整性降低。结果提示OPC功能障碍可能是家族性精神分裂症的候选病理生理机制。
要点
- CSPG4两个罕见错义突变在家族性精神分裂症家系中共分离。
- CSPG4A131T携带者iPSC来源OPC呈现加工、定位、形态、活力及髓鞘化异常。
- CSPG4A131T携带者弥散张量成像显示脑白质完整性降低。
核心结论
- 遗传与功能证据汇聚提示OPC功能障碍是家族性精神分裂症的候选病理生理机制。
研究设计与样本
- 采用家系遗传发现方法结合iPSC功能分析,并在瑞典精神分裂症外显子测序研究(2536例病例,2543例对照)中验证突变频率。
主要发现
- CSPG4A131T突变未见于瑞典精神分裂症外显子测序研究,CSPG4V901G在病例中名义富集(11例病例 vs 3例对照,P=0.026,OR 3.77,95%CI 1.05-13.52)。
- CSPG4A131T携带者iPSC来源OPC显示翻译后加工异常(P=0.029)、突变NG2亚细胞定位异常(P=0.007)、细胞形态异常(P=3.0×10-8)、活力异常(P=8.9×10-7)及髓鞘化潜能异常(P=0.038)。
- 转染健康非携带者同胞OPC证实CSPG4A131T(P=0.006)和CSPG4V901G(P=3.4×10-4)突变对细胞存活有致病效应。
- CSPG4A131T携带者体内弥散张量成像显示脑白质完整性较未受影响同胞及匹配一般人群对照降低(P=2.2×10-5)。
临床怎么用
- 该发现暂不直接改变临床诊疗,但提示对家族性精神分裂症可关注白质完整性及OPC相关机制。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia is highly heritable, yet its underlying pathophysiology remains largely unknown. Among the most well-replicated findings in neurobiological studies of schizophrenia are deficits in myelination and white matter integrity; however, direct etiological genetic and cellular evidence has thus far been lacking. Here, we implement a family-based approach for genetic discovery in schizophrenia combined with functional analysis using induced pluripotent stem cells (iPSCs). We observed familial segregation of two rare missense mutations in Chondroitin Sulfate Proteoglycan 4 (CSPG4) (c.391G > A [p.A131T], MAF 7.79 × 10-5 and c.2702T > G [p.V901G], MAF 2.51 × 10-3). The CSPG4A131T mutation was absent from the Swedish Schizophrenia Exome Sequencing Study (2536 cases, 2543 controls), while the CSPG4V901G mutation was nominally enriched in cases (11 cases vs. 3 controls, P = 0.026, OR 3.77, 95% CI 1.05-13.52). CSPG4/NG2 is a hallmark protein of oligodendrocyte progenitor cells (OPCs). iPSC-derived OPCs from CSPG4A131T mutation carriers exhibited abnormal post-translational processing (P = 0.029), subcellular localization of mutant NG2 (P = 0.007), as well as aberrant cellular morphology (P = 3.0 × 10-8), viability (P = 8.9 × 10-7), and myelination potential (P = 0.038). Moreover, transfection of healthy non-carrier sibling OPCs confirmed a pathogenic effect on cell survival of both the CSPG4A131T (P = 0.006) and CSPG4V901G (P = 3.4 × 10-4) mutations. Finally, in vivo diffusion tensor imaging of CSPG4A131T mutation carriers demonstrated a reduction of brain white matter integrity compared to unaffected sibling and matched general population controls (P = 2.2 × 10-5). Together, our findings provide a convergence of genetic and functional evidence to implicate OPC dysfunction as a candidate pathophysiological mechanism of familial schizophrenia.
引用
- de Vrij FM, Bouwkamp CG, Gunhanlar N, et al. Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia. Mol Psychiatry. 2018. PMID: 29302076. doi:10.1038/s41380-017-0004-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。